NCT00993915
Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
See it on ClinicalTrials.gov ↗687 people
41.2%
58.8%
283 womenmiddle line = equal numbers404 men
- Phase
- —
- Paid for by
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Finished
- 2011-12
- Health conditions
- Cardiovascular Diseases, Coronary Artery Disease
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- Not reported
- Age 65+
- 23.1%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.